ClinicalTrials.Veeva

Menu

Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability (IMPROVE)

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Unknown

Conditions

Inflammation
Stroke
Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT03218527
IIBSP-ATE-2015-38

Details and patient eligibility

About

Ischemic stroke is a leading cause of death and disability worldwide. Atherosclerosis, responsible for the 20% of ischemic strokes, is characterized by lipid accumulation in the artery wall that leads to chronic inflammation, cell proliferation and ultimately to vessel stenosis. One of the main features related to plaque progression and vulnerability is inflammation. Positron emission tomography with 18-fluorodeoxyglucos (18-FDG PET) allows an accurate quantification of plaque inflammation and it has been proved its usefulness in predicting early stroke recurrences. The investigators aim to test how modifiable vascular risk factors influence plaque inflammation assessed by 18-FDG PET. In addition, investigators will assess the association of this inflammation and circulating endothelial progenitor cells

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ischemic stroke within 7 days before inclusion
  • At least one atherosclerotic plaque in the internal carotid artery
  • >18 years old

Exclusion criteria

  • Cardioembolic strokes according to TOAST criteria
  • Poor functional outcome (Rankin >3) after stroke

Trial contacts and locations

1

Loading...

Central trial contact

Pol Camps-Remom, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems